Relapsing multiple sclerosis patients treated with disease modifying therapy exhibit highly variable disease...

Area of Science:

• Neurology
• Immunology
• Clinical Research

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Understanding disease progression patterns is crucial for effective management, especially during the treatment era.

Purpose of the Study:

• To define and characterize three distinct patterns of MS progression: aggressive MS (AMS), intermediate MS (IMS), and mild MS (MMS).
• To develop a predictive model for identifying patients likely to reach an Expanded Disability Status Scale (EDSS) score of 6.0.

Main Methods:

• Stratification of Relapsing MS (RMS) patients into AMS, IMS, and MMS based on the rate of change in EDSS scores.
• Comparison of EDSS progression rates before and after applying these new definitions.

Main Results:

• Significant differences in disability were observed across the three MS progression groups (p ≤ 0.001).
• Aggressive MS (AMS) patients exhibited a more severe and disabling disease course compared to the intermediate MS (IMS) group.
• 98% of patients received disease-modifying treatments (DMTs), yet distinct progression patterns persisted.

Conclusions:

• MS progression can transition to an aggressive course at any point within the first 15 years, irrespective of DMT use.
• The novel definition of AMS identifies patients who experience rapid permanent disability, even with modern treatments.
• Early identification of AMS is critical for timely intervention and management strategies.